Granules India Limited has informed the Exchange regarding a press release dated December 03, 2023, titled "Granules India Limited Received ANDA Approval for Sildenafil for Oral Suspension.".
Press Release Dec 03 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Earlier from Granules India
- Press Release Nov 09 2023
- Press Release Oct 19 2023
- Press Release Sep 30 2023
- Press Release Aug 09 2023
- Press Release Aug 04 2023
Later from Granules India
- Press Release Dec 13 2023
- Press Release Jan 23 2024
- Press Release Apr 30 2024
- Press Release May 15 2024
- Press Release Jul 30 2024
Follow Granules India into a list and get an email when it puts out news.
Follow Granules India